|
|
Volumn 13, Issue 8, 2014, Pages 568-569
|
|
Deal watch: Pfizer and GSK join race for T cell cancer therapies
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD19 ANTIGEN;
LYMPHOCYTE ANTIGEN RECEPTOR;
T LYMPHOCYTE RECEPTOR;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ALLOIMMUNITY;
ANTIGEN BINDING;
CANCER THERAPY;
CELL ACTIVATION;
CELL THERAPY;
CELL TRANSFER;
CYTOKINE PRODUCTION;
DRUG INDUSTRY;
DRUG TARGETING;
HUMAN;
NOTE;
PRIORITY JOURNAL;
SOLID TUMOR;
T LYMPHOCYTE;
DRUG INDUSTRY;
GENETIC ENGINEERING;
HUMANS;
IMMUNOTHERAPY;
NEOPLASMS;
T-LYMPHOCYTES;
|
|
EID: 84905368560
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4402 Document Type: Note |
|
Times cited : (10)
|
|
References (0)
|
